Nightware – Medical Alley Association

In the Know: Healthcare News for November 14, 2022

Veterans Find Relief from Nightmares with NightWare and Apple Watch Hennepin Healthcare Contracts with OneOme®to Offer RightMed® PGx (Pharmacogenomic) Test as Part of Personalized Medication Program Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary Upsher-Smith Expands Haloperidol Product Family to Include Unit Dose Tablets […]

Launch Minnesota Awards Over $1M in Innovation Grants to Startups

St. Paul – Today the Minnesota Department of Employment and Economic Development (DEED) announced $1,189,500 in Launch Minnesota Innovation Grant awards to startups across the state. The grants were awarded to 43 startups, over half of which are led by entrepreneurs of color, veterans, women, or located in Greater Minnesota. Launch Minnesota Innovation Grants target the […]

In the Know: Healthcare News for August 9, 2021

Ecolab Unveils Advanced Design Center to Expand on Surgical Innovation Proposed Sale of Smiths Medical NAMSA Acquires Leading Clinical Research Organization Clinlogix to Enhance Therapeutic Expertise and Global Footprint Medtronic Buying Maker of Device that Helps Chronic Sinus Problems for $936M Best Buy to Invest up to $10 Million with Brown Venture Group Former MinuteClinic […]

Up & Running with Grady Hannah, CEO and Co-founder, NightWare

Grady Hannah is a medical device executive and software entrepreneur who spent 15 years in Silicon Valley, working primarily in the real-time simulation and video game space. Upon returning to Minnesota, Grady led Business Development for Pushpin, a GIS and advanced graphics company, helping to facilitate a successful exit to Nearmap. Grady has been full-time CEO of […]

In The Know: Healthcare News for June 28

Bright Health Raises $924M, Making it the Largest IPO Ever in Minnesota Miromatrix stock up over 60% after IPO raises $43 million Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics Nu-Tek BioSciences Building $40 Million Peptone Factory […]

Medical Alley: Where Tomorrow’s Healthcare is Happening Today – 2020 Annual Report

2020 started like any other year. We were focused on increasing the value of membership, telling the Medical Alley story, and growing the region’s influence and impact. We were looking forward to our sold-out sixth Annual Dinner, presented by Bind Benefits, featuring Michael Phelps and Patrick Kennedy, as well as our full slate of in-person […]

In The Know: Healthcare News for January 18, 2021

HistoSonics Receives Approval to Begin European #HOPE4LIVER Clinical Study Steris to Acquire Cantel Medical in $4.6B Deal Recombinetics Inc. Announces Neurofibromatosis Type 1 Research Collaboration with AstraZeneca OX2’s New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials Health, Tech Groups Aim to Create Digital Covid ‘Vaccination Passport’ Respicardia Announces Highmark Coverage for the […]

In The Know: Healthcare News for December 14, 2020

Plymouth Firm Assists Vaccine Shipping with Deep-Frozen Packaging Inspire Medical Systems Included in Deloitte’s 2020 Technology Fast 500 First Nation Group offers NightWare™, A Digital Therapeutic Platform Delivered through the Apple Watch® to Interrupt PTSD-Related Nightmares, to Government Customers Abilitech Rolls Out its First Commercial Product, Will Raise $20M Bone Foam Inc. Helps ICU Workers […]

In The Know: Healthcare News for November 16, 2020

Mayo Clinic Establishes New Grant Fund for Racial Equity Medibio Partners with US Company for New Clinical Trial FDA clears Apple Watch Sleep App that Intervenes to Stop Nightmares Caused by PTSD Community Learning Pods Get Boost with Allina Health Office Space Donation Aldevron Names Shawn McCormick Chief Financial Officer Osterholm Asked to Join Biden’s […]

FDA: Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults

U.S. Food and Drug Administration issued the following announcement on Nov. 6. The U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). The […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER